ctrl K

Watchlist Price Alert

Stoke Therapeutics Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

9.71

0.28 (2.97%)

At close: May 29, 2025, 3:59 PM

9.45

-2.68%

After-hours: May 29, 2025, 07:44 PM EDT

Stoke Therapeutics Revenue Breakdown

Period Ending	Dec 31, 2024
License Revenue	29.4M
License Revenue Growth	n/a
Service Revenue	7.2M
Service Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Selling, General, and Administrative Revenue	14.65M	12.84M	12.69M	12.47M	9.67M	10.02M	10.27M	10.23M	10.21M	9.38M	9.94M	10.11M	9.49M	8.72M	8.32M	7.93M	6.91M	5.68M	5.6M	5.04M	4.52M	3.98M	3.32M	2.42M	2.19M	1.54M	1.09M	1.12M	660K
Selling, General, and Administrative Revenue Growth	+14.08%	+1.20%	+1.74%	+29.01%	-3.48%	-2.45%	+0.40%	+0.19%	+8.82%	-5.64%	-1.65%	+6.59%	+8.73%	+4.79%	+4.93%	+14.75%	+21.68%	+1.43%	+11.06%	+11.59%	+13.60%	+19.71%	+37.24%	+10.64%	+42.33%	+41.10%	-2.85%	+70.00%	n/a
Research and Development Revenue	32.68M	23.42M	22.2M	20.59M	21.8M	21.15M	20.27M	20.55M	19.63M	21.06M	20.11M	18.36M	18.31M	15.8M	14.36M	14.1M	9.91M	8.9M	8.11M	7.97M	7.21M	7.09M	6.52M	6.02M	4.13M	3M	2.23M	1.89M	1.25M
Research and Development Revenue Growth	+39.50%	+5.49%	+7.85%	-5.58%	+3.08%	+4.36%	-1.36%	+4.69%	-6.79%	+4.73%	+9.54%	+0.27%	+15.87%	+10.06%	+1.87%	+42.19%	+11.33%	+9.80%	+1.77%	+10.44%	+1.78%	+8.76%	+8.22%	+45.73%	+37.58%	+34.89%	+17.96%	+50.80%	n/a